GIM
LLY icon

Groesbeck Investment Management’s Eli Lilly LLY Stock Holding History

Groesbeck Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,450
Closed -$203K – 96
2014
Q1 		$203K Sell
3,450
-40,000
-92% -$2.23M 0.09% 84
2013
Q4 		$2.22M Sell
43,450
-53,700
-55% -$2.69M 0.92% 46
2013
Q3 		$4.89M Sell
97,150
-150
-0.2% -$7.85K 2.12% 20
2013
Q2 		$4.78M Buy
+97,300
New +$5.29M 2.02% 21

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Groesbeck Investment Management's LLY Position: Q2 2014 in Review

Groesbeck Investment Management sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 3,450 shares — an estimated $203K sold.

Groesbeck Investment Management first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $4.89M in Q3 2013. 1,029 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • Groesbeck Investment Management reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
  • Groesbeck Investment Management sold 3,450 Eli Lilly shares in Q2 2014, an estimated $203K.
  • Groesbeck Investment Management first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
  • Groesbeck Investment Management's Eli Lilly position peaked at $4.89M in Q3 2013.
  • 1,029 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on Groesbeck Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.